• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Monogram Biosciences, Inc. (MGRM) - Financial and Strategic Analysis Review Product Image

Monogram Biosciences, Inc. (MGRM) - Financial and Strategic Analysis Review

  • Published: September 2010
  • Region: Global
  • 30 pages
  • GlobalData

Monogram Biosciences, Inc. (Monogram) is a life sciences company engaged in developing and commercializing innovative products that help, guide and improve the treatment of infectious diseases, cancer and other serious diseases. The company's products for HIV testing include GeneSeq HIV, PhenoSense HIV Entry, and PhenoSense HIV Integrase, Geneseq HIV, and Geneseq HIV. Monogram Biosciences, Inc. was acquired by Laboratory Corporation of America. The company is headquartered in California, the US.

Monogram Biosciences, Inc. Key Recent Developments

Aug 04, 2009 LabCorp Completes Acquisition Of Monogram Biosciences
Jul 17, 2009 Laboratory Corporation Of America, Monogram's Waiting Period Under Antitrust Improvements Expired
Jun 30, 2009 Brodsky & Smith Files Class Action Lawsuit Against Monogram
Jun 23, 2009 LabCorp Signs Agreement To Acquire Monogram Biosciences
Jan 15, 2009 Monogram Reports Preliminary 2008 Results

This comprehensive SWOT profile of Monogram Biosciences, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an READ MORE >



List of Tables
List of Figures
Section 1 - About the Company
Monogram Biosciences, Inc. - Key Facts
Monogram Biosciences, Inc. - Key Employees
Monogram Biosciences, Inc. - Key Employee Biographies
Monogram Biosciences, Inc. - Major Products and Services
Monogram Biosciences, Inc. - History
Monogram Biosciences, Inc. - Company Statement
Monogram Biosciences, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Monogram Biosciences, Inc. - Business Description
Monogram Biosciences, Inc. - SWOT Analysis
SWOT Analysis - Overview
Monogram Biosciences, Inc. - Strengths
Strength - Market Leadership in HIV Drug Resistance Testing
Strength - Sturdy Research and Development Activities
Monogram Biosciences, Inc. - Weaknesses
Weakness - Losses from Operations
Monogram Biosciences, Inc. - Opportunities
Opportunity - Emerging Markets
Opportunity - Market Potential: Cancer
Opportunity - Market Potential: HIV
Opportunity - Acquisition agreement
Monogram Biosciences, Inc. - Threats
Threat - Intense Competition
Threat - Pricing Pressures
Threat - Tightening of FDA’s Regulatory Oversight
Monogram Biosciences, Inc. - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
Aug 04, 2009: LabCorp Completes Acquisition Of Monogram Biosciences
Jul 17, 2009: Laboratory Corporation Of America, Monogram's Waiting Period Under Antitrust Improvements Expired
Jun 30, 2009: Brodsky & Smith Files Class Action Lawsuit Against Monogram
Jun 23, 2009: LabCorp Signs Agreement To Acquire Monogram Biosciences
Jan 15, 2009: Monogram Reports Preliminary 2008 Results
Section 5 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

Monogram Biosciences, Inc. (Monogram) is a life sciences company engaged in developing and commercializing innovative products that help, guide and improve the treatment of infectious diseases, cancer and other serious diseases. The company's products for HIV testing include GeneSeq HIV, PhenoSense HIV Entry, and PhenoSense HIV Integrase, Geneseq HIV, and Geneseq HIV. Monogram Biosciences, Inc. was acquired by Laboratory Corporation of America. The company is headquartered in California, the US.

Note: Product cover images may vary from those shown

RELATED PRODUCTS